Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Both medications have shown significant efficacy in promoting weight loss, but tirzepatides dual action might provide an added advantage for some patients
Shima Hadidchi, MD , takes a personalized approach to monitoring her patients progress on semaglutide GLP-1 or Zepbound for weight loss
23 The results clearly favored Zepbound
The SURMOUNT-1 clinical trial tracked weight loss outcomes across all three maintenance dose tiers over 72 weeks in adults with obesity or overweight
Semaglutide is a GLP-1 medication approved by the US Food and Drug Administration (FDA) that controls blood sugar levels in people with type 2 diabetes, reduces the risk of heart attack and stroke in people with heart disease and type 2 diabetes or obesity, and promotes weight loss in people with overweight and obesity
US$ 20.62
US$ 27.16
US$ 24.66
US$ 23.31
US$ 22.90
US$ 26.66
US$ 24.46
US$ 25.25
US$ 28.91
